???global.info.a_carregar???
Elsa Cristina Vieira de Sousa. Publicou 53 artigos em revistas especializadas. Atua na(s) área(s) de Ciências Médicas e da Saúde com ênfase em Medicina Clínica com ênfase em Reumatologia. No seu currículo Ciência Vitae os termos mais frequentes na contextualização da produção científica, tecnológica e artístico-cultural são: anti-TNF; methotrexate; outcomes research; psoriatic arthritis; DMARDs (biologic); disease activity; spondyloarthritis; TNF inhibitors; axial spondyloarthritis; treatment outcomes; arthritis; early rheumatoid arthritis; patient perspective; rheumatoid arthritis; ultrasonography; Arthritis; Psoriatic; *drug therapy; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Treatment Outcome; Tumor Necrosis Factor-alpha; *antagonists {\&; Csf1r; NFATc1; Rank; ankylosing spondylitis; gene expression; humans; monocytes; osteoclasts; Biomarkers; metabolism; Biomedical Research; Rheumatoid; *diagnosis; Synovial Fluid; Synovial Membrane; cytology; *pathology; Adult; Age Factors; complications; diagnostic imag; Cross-Sectional Studies; Inflammatory Bowel Diseases; *patholo; Latin America; epidemiology; Radiography; Sex Factors; Spondylitis; Ankylosing; diagnostic imaging; epidemi; etiology; *cell receptor interaction; *hormones; *macrophages; *rheumatoid arthritis; *signalling and activation; *synovium; Antigens; CD; immunology; *metabolism; Cytokines; Enzyme-Linked Immunosorbent Assay; Macrophage Activation; *physiology; Macrophages; RNA; Messenger; Real-Time Polymerase Chain Reaction; Receptors; Prolactin; Up-Regulation; Arthroscopic guided synovial biopsy; Osteoarticular tuberculosis; Tuberculosis; Anti-Inflammatory Agents; Non-Steroidal; therapeuti; Antibodies; Monoclonal; *therapeutic use; Antirheumatic Agents; therapeutic use; B-Lymphocytes; Bone Resorption; blood; Gene Expression Profiling; Immunophenotyping; Inflammation Mediators; Molecular Targeted Therapy; Osteoclasts; *drug effects; Phenotype; RANK Ligand; *; T-Lymphocytes; Tumor Necrosis Factors; *Arthritis; *Finger Joint; *Toe Joint; *Biological Therapy; diagnosis; *therapy; *Severity of Illness Index; Acute-Phase Proteins; drug therapy; Patient Acceptance of Health Care; statistics {\&; Animals; Disease Models; Animal; Spondylarthritis; *etiology; *physiopathology; B27-haplotypes; HLA alleles; HLA class I and II; phenotypic features; Aged; Aminopeptidases; *genetics; Case-Control Studies; Erap1; Genetic Predisposition to Disease; genetics; Genotype; HLA-B27 Antigen; Haplotypes; Il23r; Linkage Disequilibrium; Minor Histocompatibility Antigens; Polymorphism; Single Nucleotide; Interleukin; Tnfsf15; Tumor Necrosis Factor Ligand Superfamily Member 15; protection haplotype; *Magnetic Resonance Imaging; Acute Disease; Low Back Pain; Biological Therapy; *standards; Ankylosing spondylitis; Genetic predisposition; Morbidity; Portugal; Severity of Illness Index; Surveys and Questionnaires; *Bone Density; Absorptiometry; Photon; 80 and over; Biomechanical Phenomena; Bone Diseases; *complications; physiopathology; Femur Neck; pathology; Hip Fractures; Osteoarthritis; Risk Factors; Smoking; *adverse effects; phy; Disease Progression; Drug Resistance; Evidence-Based Medicine; Monitoring; Physiologic; Recurrence; Risk; Rheumatoid arthritis; biomarkers; clinical trial design; synovial tissue; treatment; *phy; Databases; Factual; patholo; Quality of Life; *physiopathol; Arthroscopy; methods; Biopsy; *methods; standards; Clinical Trials as Topic; Interventional; Knee Joint; Multicenter Studies as Topic; Synovitis; Ultrasonography; *immunology; analysis; Flow Cytometry; Lymphocyte Activation; Neutrophils; Th17 Cells; .
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Elsa Cristina Vieira de Sousa

Nomes de citação

  • Vieira-Sousa, Elsa

Identificadores de autor

Ciência ID
1519-509A-8B89
ORCID iD
0000-0002-7170-8802

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Clínica - Reumatologia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador independente (B2) Utilizador proficiente (C1) Utilizador proficiente (C1)
Francês Utilizador elementar (A1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador elementar (A1)
Espanhol; Castelhano Utilizador elementar (A1) Utilizador independente (B2) Utilizador elementar (A1) Utilizador independente (B2)
Formação
Grau Classificação
2019/12/20
Concluído
 Programa Doutoral do Centro Académico de Medicina de Lisboa (ramo de Medicina; ramo de Ciências Biomédicas; ramo de Ciências e Tecnologias da Saúde) (Doutoramento)
Especialização em Medicina-Reumatologia
Universidade de Lisboa Faculdade de Medicina, Portugal
"NEW PERSPECTIVES ON TUMOR NECROSIS FACTOR INHIBITION FOR THE TREATMENT OF PSORIATIC ARTHRITIS" (TESE/DISSERTAÇÃO)
 Aprovada com distinção e louvor por unanimidade
2009 - 2018
Concluído
 Assistente Hospitalar em Reumatologia (Título de especialista)
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2009
Concluído
 Internato Médico em Reumatologia (Especialização pós-licenciatura)
Especialização em Reumatologia
Hospital de Santa Maria, Portugal
2001
Concluído
 Medicina (Licenciatura)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2005 - Atual Investigador (Investigação) Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
2009 - 2010 Estagiário de Investigação (Investigação) University of Glasgow, Reino Unido
University of Glasgow Institute of Infection Immunity and Inflammation, Reino Unido
(...)

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2020 - Atual Professor Auxiliar Convidado (Docente Universitário) Universidade de Lisboa Faculdade de Medicina, Portugal
2005 - 2019 Assistente Convidado (Docente Universitário) Universidade de Lisboa Faculdade de Medicina, Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
2018 - Atual Assistente graduado (Médica) Centro Hospitalar Universitário Lisboa Norte EPE, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento 		Empregador
2021/06 - Atual Membro do Comité Executivo Fundação para a Investigação em Reumatologia (FOREUM), Suiça
Fundação para a Investigação em Reumatologia (FOREUM), Suiça
2016 - Atual Coordenadora da Unidade de Ensaios Clínicos do Serviço de Reumatologia do Hospital de Santa Maria Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2014 - 2020 Editor-Chefe da Acta Reumatológica Portuguesa Sociedade Portuguesa de Reumatologia, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2016 - Atual Membro de grupos de Task Force para o Centro de Investigação Clínica do Centro Académico de Medicina de Lisboa Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2014 - 2018 Coordenador do Grupo de Estudos em Espondilartrites Sociedade Portuguesa de Reumatologia, Portugal
2014 - 2016 Vice-Secretária Geral da Sociedade Portuguesa de Reumatologia Sociedade Portuguesa de Reumatologia, Portugal
2012 - 2014 Membro da Direcção da Sociedade Portuguesa de Osteoporose e Doenças Ósseas Metabólicas Sociedade Portuguesa de Osteoporose e Doenças Ósseas Metabólicas, Portugal
2010 - 2014 Membro da Comissão Coordenadora da Base de dados Reuma.pt da Sociedade Portuguesa de Reumatologia Sociedade Portuguesa de Reumatologia, Portugal
Projetos

Bolsa

Designação Financiadores
2020 - Atual New biologic and targeted synthetic disease modifying antirheumatic drugs for the treatment of PsA: a comparative effectiveness study.
Reuma.pt SPR
Investigador responsável
2018 - Atual MILES STUDY – Mesotherapy In Lateral Epicondylitis, a prospective randomized controlled Study
CHULN
Investigador
2017 - Atual Linking biomechanics and the immune system in early Psoriatic Arthritis – a translational approach.
Pfizer
Investigador responsável
Pfizer Portugal, Portugal
2017 - Atual Bolsa Celgene/SPR Avaliação Multidisciplinar na Artrite Psoriática
Celgene
Orientador
Sociedade Portuguesa de Reumatologia, Portugal
2016 - Atual “Predictors of radiographic progression in psoriatic arthritis patients”.
GAPIC
Orientador
Universidade de Lisboa Faculdade de Medicina, Portugal
2014 - Atual Linking Biomechanics, Inflammation and Bone Formation in Psoriatic Arthritis
UCB
Investigador
UCB Celltech, Reino Unido
2014 - 2020 Golimumab as first line DMARD therapy in MTX naive psoriatic arthritis - a 24 weeks efficacy and safety study focusing on dactylitis and enthesitis.
MSD
Investigador responsável
2005 - 2010 Polymorphisms of the Tumor Necrosis Factor alpha gene promoter and Spondyloarthropaties: discrimination of subtypes, prognosis and pharmacogenetics of TNF-alpha blocking therapies.
CHULN
Investigador
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2004 - 2010 Sequencing of the promoter of the Tumor Necrosis Factor alpha (TNF- alpha) gene: contribution for markers of rheumatoid arthritis prognosis and of anti TNF- alpha response.
POCTI/SAU-ESP/59111/2004
Investigador
Concluído

Outro

Designação Financiadores
2017 - 2020 Effect of biologic disease-modifying antirheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis
Novartis
Orientador
Produções

Publicações

Artigo em revista
  1. Leal, Inês; Romão, Vasco C; Mano, Sofia; Khmelinskii, Nikita; Campanilho-Marques, Raquel; Ponte, Cristina; Macieira, Carla; et al. "A Non-Infectious Uveitis Multidisciplinary Clinic in a Tertiary Referral Center: Clinical Impact and Added Value". Journal of Multidisciplinary Healthcare Volume 14 (2021): 695-704. http://dx.doi.org/10.2147/jmdh.s292981.
    Publicado • 10.2147/jmdh.s292981
  2. Orr, Carl Kieran; Vieira-Sousa, Elsa; Fonseca, João Eurico; Veale, Douglas. "Arthroscopic Guided Synovial Biopsies". Frontiers in Medicine 7 (2021): http://dx.doi.org/10.3389/fmed.2020.604582.
    10.3389/fmed.2020.604582
  3. Manica, Santiago Rodrigues; Sepriano, Alexandre; Pimentel-Santos, Fernando; Gouveia, Nélia; Barcelos, Anabela; Branco, Jaime C.; Bernardes, Miguel; et al. "Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?". Arthritis Research & Therapy 22 1 (2020): http://dx.doi.org/10.1186/s13075-020-02288-8.
    10.1186/s13075-020-02288-8
  4. Cruz-Machado, Ana Rita; Rodrigues-Manica, Santiago; Silva, Joana Leite; Alho, Irina; Coelho, Constança; Duarte, Joana; Florêncio, Cláudia; et al. "Effect of biologic disease-modifying anti-rheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis". Rheumatology 59 11 (2020): 3158-3171. http://dx.doi.org/10.1093/rheumatology/keaa268.
    10.1093/rheumatology/keaa268
  5. Rodrigues-Manica, Santiago; Silva, Joana; Cruz-Machado, Rita; Coelho, Constança; Duarte, Joana; Vieira-Sousa, Elsa; Tavares-Costa, José; Pimentel-Santos, Fernando M.. "Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action". Clinical Rheumatology 40 1 (2020): 33-41. http://dx.doi.org/10.1007/s10067-020-05209-x.
    10.1007/s10067-020-05209-x
  6. Romão, Vasco C; Cordeiro, Inês; Macieira, Carla; Oliveira-Ramos, Filipa; Romeu, José Carlos; Rosa, Carlos Miranda; Saavedra, Maria João; et al. "Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view". RMD Open 6 2 (2020): e001314. http://dx.doi.org/10.1136/rmdopen-2020-001314.
    10.1136/rmdopen-2020-001314
  7. Sousa, Elsa. "GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis.". Annals of the rheumatic diseases 79 4 (2020): 490-498. http://www.ncbi.nlm.nih.gov/pubmed/32193187 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC7147178.
    10.1136/annrheumdis-2019-216500
  8. Sousa, Elsa. "The Importance of Timely Diagnosing Tuberculous Arthritis: The Role of Ultrasound-Guided Biopsy.". Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2020): http://www.ncbi.nlm.nih.gov/pubmed/32091455.
    10.1097/RHU.0000000000001346
  9. Sousa, Elsa. "Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI.". RMD open 6 1 (2020): http://www.ncbi.nlm.nih.gov/pubmed/32144137 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC7061099.
    10.1136/rmdopen-2019-001145
  10. Sousa, Elsa. "Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.". Rheumatology (Oxford, England) (2020): http://www.ncbi.nlm.nih.gov/pubmed/31960053.
    10.1093/rheumatology/kez656
  11. Sousa, Elsa. "Real-World Long-Term Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register.". The Journal of rheumatology (2019): http://www.ncbi.nlm.nih.gov/pubmed/31371659.
    10.3899/jrheum.181272
  12. Sousa, Elsa. "Efficacy, safety and sample quality of ultrasound-guided synovial needle biopsy in clinical practice and research: a prospective observational study.". Arthritis care & research (2019): http://www.ncbi.nlm.nih.gov/pubmed/31421034.
    10.1002/acr.24050
  13. Sousa, Elsa. "Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe.". RMD open 4 2 (2018): e000799-e000799. http://www.ncbi.nlm.nih.gov/pubmed/30488001 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6241983.
    10.1136/rmdopen-2018-000799
  14. Sousa, Elsa. "A multi centre retrospective analysis evaluating performance of synovial biopsy techniques: arthroscopic vs. ultrasound guided vs. blind needle biopsy". Arthritis Rheumatol (2018): https://www.ncbi.nlm.nih.gov/pubmed/29409140.
    10.1002/art.40433
  15. Sousa, Elsa. "Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 update.". Acta reumatologica portuguesa 43 1 (2018): 10-31. http://www.ncbi.nlm.nih.gov/pubmed/29602163.
  16. Sousa, Elsa. "The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy.". Acta reumatologica portuguesa 43 2 (2018): 80-92. http://www.ncbi.nlm.nih.gov/pubmed/30091952.
  17. Sousa, Elsa. "Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 update". Acta Reumatol Port 42 3 (2017): 209-218. https://www.ncbi.nlm.nih.gov/pubmed/28894079.
  18. Sousa, Elsa. "Predictors of response to TNF blockers in patients with polyarticular psoriatic arthritis". Acta Reumatol Port 42 1 (2017): 55-65. https://www.ncbi.nlm.nih.gov/pubmed/27750274.
  19. Sousa, Elsa. "Corrigendum: Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors". Front Med (Lausanne) 4 (2017): 38-38. https://www.ncbi.nlm.nih.gov/pubmed/28405583 https://www.ncbi.nlm.nih.gov/pubmed/28191455.
    10.3389/fmed.2017.00005
  20. Sousa, Elsa. "Acta Reumatologica Portuguesa: perspectives in 2017". Acta Reumatol Port 42 2 (2017): 110-111. https://www.ncbi.nlm.nih.gov/pubmed/28693032.
  21. Sousa, Elsa. "Synovial tissue research: a state-of-the-art review". Nat Rev Rheumatol 13 10 (2017): 463-475. https://www.ncbi.nlm.nih.gov/pubmed/28935945 https://www.ncbi.nlm.nih.gov/pubmed/28701760 https://www.ncbi.nlm.nih.gov/pubmed/29255214.
    10.1038/nrrheum.2017.161
  22. Sousa, Elsa. "Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update.". Acta reumatologica portuguesa 42 2 (2017): 127-140. http://www.ncbi.nlm.nih.gov/pubmed/28535545.
  23. Sousa, Elsa. "Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 update.". Acta reumatologica portuguesa 42(2) Apr-Jun (2017): 112-126. http://www.ncbi.nlm.nih.gov/pubmed/28535544.
  24. Sousa, Elsa. "Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort". Medicine (Baltimore) 95 51 (2016): e5652-e5652. https://www.ncbi.nlm.nih.gov/pubmed/28002334.
    10.1097/MD.0000000000005652
  25. Sousa, Elsa. "The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation". Rheumatology (Oxford) 55 12 (2016): 2248-2259. https://www.ncbi.nlm.nih.gov/pubmed/27616146.
    10.1093/rheumatology/kew316
  26. Sousa, Elsa. "A diagnosis of disseminated tuberculosis based on knee arthroscopic guided synovial biopsy in the context of monoarthritis". Acta Reumatologica Portuguesa 2016 3 (2016): 256-259. https://www.ncbi.nlm.nih.gov/pubmed/27155318.
  27. Sousa, Elsa. "Investigator initiated trials in Portuguese rheumatology.". Acta reumatologica portuguesa 41 2 (2016): 101-3. http://www.ncbi.nlm.nih.gov/pubmed/27606469.
  28. Sousa, Elsa. "Effect of Comedication With Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study.". Arthritis & rheumatology (Hoboken, N.J.) 68 11 (2016): 2671-2679. http://www.ncbi.nlm.nih.gov/pubmed/27273894.
    10.1002/art.39772
  29. Sousa, Elsa. "Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis". PLoS One 10 12 (2015): e0144655-e0144655. https://www.ncbi.nlm.nih.gov/pubmed/26674064.
    10.1371/journal.pone.0144655
  30. Sousa, Elsa. "Dactylitis: more than just arthritis". Acta Reumatol Port 40 3 (2015): 210-212. https://www.ncbi.nlm.nih.gov/pubmed/26535776.
  31. Sousa, Elsa. "The impact factor dictatorship". Acta Reumatol Port 40 4 (2015): 322-322. https://www.ncbi.nlm.nih.gov/pubmed/26922194.
  32. Sousa, Elsa. "Portuguese Recommendations for the Use of Biological Therapies in Patients with Psoriatic Arthritis--2015 Update". Acta Reumatol Port 40 3 (2015): 275-290. https://www.ncbi.nlm.nih.gov/pubmed/26610694.
  33. Sousa, Elsa. "DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt". Rheumatology (Oxford) 54 2 (2015): 286-291. https://www.ncbi.nlm.nih.gov/pubmed/25173347.
    10.1093/rheumatology/keu313
  34. Sousa, Elsa. "Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis". Arthritis Rheumatol 67 11 (2015): 2813-2827. https://www.ncbi.nlm.nih.gov/pubmed/26215401.
    10.1002/art.39282
  35. Sousa, Elsa. "HLA alleles and HLA-B27 haplotypes associated with susceptibility and severity of ankylosing spondylitis in a Portuguese population.". Tissue antigens 82 6 (2013): 374-9. http://www.ncbi.nlm.nih.gov/pubmed/24498993.
    10.1111/tan.12238
  36. Sousa, Elsa. "An analysis of 372 patients with anterior uveitis in a large Ibero-American cohort of spondyloarthritis: the RESPONDIA Group.". Clinical and experimental rheumatology 31 4 (2013): 484-9. http://www.ncbi.nlm.nih.gov/pubmed/23899968.
  37. Sousa, Elsa. "Protective effect of an ERAP1 haplotype in ankylosing spondylitis: investigating non-MHC genes in HLA-B27-positive individuals". Rheumatology (Oxford) 52 12 (2013): 2168-2176. https://www.ncbi.nlm.nih.gov/pubmed/24046467.
    10.1093/rheumatology/ket269
  38. Sousa, Elsa. "Acute low back pain - a clinical and imaging challenge". Acta Reumatol Port 38 2 (2013): 133-135. https://www.ncbi.nlm.nih.gov/pubmed/24141352.
  39. Sousa, Elsa. "Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America.". The Journal of rheumatology 39 12 (2012): 2315-20. http://www.ncbi.nlm.nih.gov/pubmed/23149388.
    10.3899/jrheum.110687
  40. Sousa, Elsa. "2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis". Acta Reumatol Port 37 1 (2012): 26-39. https://www.ncbi.nlm.nih.gov/pubmed/22781512.
  41. Sousa, Elsa. "ANKH and susceptibility to and severity of ankylosing spondylitis". Journal of Rheumatology 39 1 (2012):
    10.3899/jrheum.110681
  42. Sousa, Elsa. "Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, BASMI and mSASSS reference centile charts". Clin Rheumatol 31 3 (2012): 447-454. https://www.ncbi.nlm.nih.gov/pubmed/22009195.
    10.1007/s10067-011-1854-7
  43. Sousa, Elsa. "Smoking is a predictor of worse trabecular mechanical performance in hip fragility fracture patients". J Bone Miner Metab 30 6 (2012): 692-699. https://www.ncbi.nlm.nih.gov/pubmed/22886402.
    10.1007/s00774-012-0370-4
  44. Sousa, Elsa. "Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival.". Rheumatology (Oxford, England) 50 2 (2011): 278-82. http://www.ncbi.nlm.nih.gov/pubmed/21047805.
    10.1093/rheumatology/keq338
  45. Sousa, Elsa. "Rheumatoid arthritis: what is refractory disease and how to manage it?". Autoimmun Rev 10 11 (2011): 707-713. https://www.ncbi.nlm.nih.gov/pubmed/21570496.
    10.1016/j.autrev.2011.04.023
  46. Sousa, Elsa. "Synovial tissue response to treatment in rheumatoid arthritis". Open Rheumatol J 5 (2011): 115-122. https://www.ncbi.nlm.nih.gov/pubmed/22279510.
    10.2174/1874312901105010115
  47. Sousa, Elsa. "Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease". J Rheumatol 38 8 (2011): 1656-1660. https://www.ncbi.nlm.nih.gov/pubmed/21632676.
    10.3899/jrheum.101049
  48. Sousa, Elsa. "Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials". Ann Rheum Dis 70 3 (2011): 423-427. https://www.ncbi.nlm.nih.gov/pubmed/21109518.
    10.1136/ard.2010.139550
  49. Sousa, Elsa. "Alterations on peripheral blood B-cell subpopulations in very early arthritis patients.". Rheumatology (Oxford, England) 49 6 (2010): 1082-92. http://www.ncbi.nlm.nih.gov/pubmed/20211867.
    10.1093/rheumatology/keq029
  50. Sousa, Elsa. "Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery.". Rheumatology (Oxford, England) 49 1 (2010): 73-81. http://www.ncbi.nlm.nih.gov/pubmed/19605374.
    10.1093/rheumatology/kep174
  51. Sousa, Elsa. "Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis". Arthritis Res Ther 12 5 (2010): R196-R196. https://www.ncbi.nlm.nih.gov/pubmed/20961415.
    10.1186/ar3168
  52. Sousa, Elsa. "From a neutrophilic synovial tissue infiltrate to a challenging case of rheumatoid arthritis.". Acta reumatologica portuguesa 35 2 (2010): 228-31. http://www.ncbi.nlm.nih.gov/pubmed/20711094.
  53. Sousa, Elsa. "Ankylosing spondylitis susceptibility and severity--contribution of TNF gene promoter polymorphisms at positions -238 and -308.". Annals of the New York Academy of Sciences 1173 (2009): 581-8. http://www.ncbi.nlm.nih.gov/pubmed/19758203.
    10.1111/j.1749-6632.2009.04758.x
  54. Sousa, Elsa. "Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.". Best practice & research. Clinical rheumatology 23 4 (2009): 563-74. http://www.ncbi.nlm.nih.gov/pubmed/19591785.
    10.1016/j.berh.2008.12.006
  55. Sousa, Elsa. "Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients.". Clinical rheumatology 28 8 (2009): 915-21. http://www.ncbi.nlm.nih.gov/pubmed/19390908.
    10.1007/s10067-009-1175-2
  56. Sousa, Elsa. "[Practical guide for the use of biotechnological therapies in rheumatoid arthritis].". Acta reumatologica portuguesa 34 2B (2009): 395-9. http://www.ncbi.nlm.nih.gov/pubmed/19727050.
  57. Sousa, Elsa. "Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population.". Clinical and experimental rheumatology 27 5 (2009): 800-6. http://www.ncbi.nlm.nih.gov/pubmed/19917163.
  58. Sousa, Elsa. "Evaluation of bone mechanical strenght and fracture risk assessment (Frax) in patients with hip joint replacement surgery.". Acta reumatologica portuguesa 34 3 (2009): 504-10. http://www.ncbi.nlm.nih.gov/pubmed/19830928.
  59. Sousa, Elsa. "Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter.". Arthritis research & therapy 9 2 (2007): R37-R37. http://www.ncbi.nlm.nih.gov/pubmed/17408492 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1906815.
    10.1186/ar2173
Distinções

Prémio

2020 Prémio Menção Honrosa Comunicação Oral (Co-autor)
2020 Prémio João Lobo Antunes Merit PhD Thesis Award 2020 (1º autor)
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
2019 1º Prémio Janssen Immunology Real World Evidence Award 2019 (1º autor)
2019 Prémio Dor da Fundação Grunenthal Award (Co-autor)
Fundação Grünenthal, Portugal
2019 Prémio Melhor Poster (1º author)
Sociedade Portuguesa de Reumatologia, Portugal
2017 Prémio-Menção Honrosa – Comunicação Oral

Outra distinção

2020 Bolsa JAKIE 2º Prémio (Orientador)
Sociedade Portuguesa de Reumatologia, Portugal
2011 Bolsa de Investigação Sociedade Portuguesa de Reumatologia/ MSD 2011 (1º autor)
Sociedade Portuguesa de Reumatologia, Portugal
2008 Prémio Bial 2008 (Co-author)
Bial, Portugal
2005 Melhor Caso Clínico 2005 Acta Reumatológica Portuguesa (1º autor)
Sociedade Portuguesa de Reumatologia, Portugal
2005 Prémio Hospital de Santa Maria/ Sanofi-Aventis (1º autor)
Hospital de Santa Maria, Portugal